The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variant
Mehul S. Suthar, Kelly E. Manning, Madison L Ellis, Shilpi Jain, Kareem Bechnak, Jake Vander Velden, Farida Laboune, Amy R. Henry, Sucheta Godbole, Sung Jin Kim, Malaya K. Sahoo, Isabel Paredes, Serena Maria Dib, Suha Kalash, Christelle Radi, Heather Hicks, Azaibi Tamin, Meredith E. Davis-Gardner, Nicole E. Bowen, Peter W. Cook, Clinton R. Paden, Jennifer L. Harcourt, Benjamin A. Pinsky, Daniel C. Douek, Nadine Rouphael, Alberto Moreno
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Virology2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineInternal medicineOutbreakInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchImmunodeficiency and Autoimmune DisordersBlood groups and transfusion